These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 34428777)

  • 21. The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum.
    Lu L; Chu AW; Zhang RR; Chan WM; Ip JD; Tsoi HW; Chen LL; Cai JP; Lung DC; Tam AR; Yau YS; Kwan MY; To WK; Tsang OT; Lee LL; Yi H; Ip TC; Poon RW; Siu GK; Mok BW; Cheng VC; Chan KH; Yuen KY; Hung IF; To KK
    EBioMedicine; 2021 Sep; 71():103544. PubMed ID: 34419925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants.
    Chakraborty C; Sharma AR; Bhattacharya M; Agoramoorthy G; Lee SS
    mBio; 2021 Aug; 12(4):e0114021. PubMed ID: 34465019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variants of SARS-CoV-2, their effects on infection, transmission and neutralization by vaccine-induced antibodies.
    Wahid M; Jawed A; Mandal RK; Dailah HG; Janahi EM; Dhama K; Somvanshi P; Haque S
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5857-5864. PubMed ID: 34604978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
    Jia Z; Gong W
    J Korean Med Sci; 2021 May; 36(18):e124. PubMed ID: 33975397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
    Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
    Elife; 2021 Aug; 10():. PubMed ID: 34435953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients.
    Carreño JM; Alshammary H; Singh G; Raskin A; Amanat F; Amoako A; Gonzalez-Reiche AS; van de Guchte A; Study Group P; Srivastava K; Sordillo EM; Sather DN; van Bakel H; Krammer F; Simon V
    EBioMedicine; 2021 Nov; 73():103626. PubMed ID: 34688034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil.
    Resende PC; Gräf T; Paixão ACD; Appolinario L; Lopes RS; Mendonça ACDF; da Rocha ASB; Motta FC; Neto LGL; Khouri R; de Oliveira CI; Santos-Muccillo P; Bezerra JF; Teixeira DLF; Riediger I; Debur MDC; Ribeiro-Rodrigues R; Leite AB; do Santos CA; Gregianini TS; Fernandes SB; Bernardes AFL; Cavalcanti AC; Miyajima F; Sachhi C; Mattos T; da Costa CF; Delatorre E; Wallau GL; Naveca FG; Bello G; Siqueira MM
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33919314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization.
    Zhang L; Cui Z; Li Q; Wang B; Yu Y; Wu J; Nie J; Ding R; Wang H; Zhang Y; Liu S; Chen Z; He Y; Su X; Xu W; Huang W; Wang Y
    Commun Biol; 2021 Oct; 4(1):1196. PubMed ID: 34645933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of the E484K mutation of SARS-CoV-2 on the neutralizing activity of antibodies from BNT162b2 vaccinated individuals.
    Uwamino Y; Yokoyama T; Shimura T; Nishimura T; Sato Y; Wakui M; Kosaki K; Hasegawa N; Murata M
    Vaccine; 2022 Mar; 40(13):1928-1931. PubMed ID: 35183387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron.
    Schröder S; Richter A; Veith T; Emanuel J; Gudermann L; Friedmann K; Jeworowski LM; Mühlemann B; Jones TC; Müller MA; Corman VM; Drosten C
    Virol J; 2023 Nov; 20(1):257. PubMed ID: 37940989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.
    Wang R; Zhang Q; Ge J; Ren W; Zhang R; Lan J; Ju B; Su B; Yu F; Chen P; Liao H; Feng Y; Li X; Shi X; Zhang Z; Zhang F; Ding Q; Zhang T; Wang X; Zhang L
    Immunity; 2021 Jul; 54(7):1611-1621.e5. PubMed ID: 34166623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Key Substitutions in the Spike Protein of SARS-CoV-2 Variants Can Predict Resistance to Monoclonal Antibodies, but Other Substitutions Can Modify the Effects.
    Lusvarghi S; Wang W; Herrup R; Neerukonda SN; Vassell R; Bentley L; Eakin AE; Erlandson KJ; Weiss CD
    J Virol; 2022 Jan; 96(1):e0111021. PubMed ID: 34668774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2.
    Tsai MS; Yang YH; Lin YS; Chang GH; Hsu CM; Yeh RA; Shu LH; Cheng YC; Liu HT; Wu YH; Wu YH; Shen RC; Wu CY
    Biomed Pharmacother; 2021 Oct; 142():112011. PubMed ID: 34388530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of spike mutations on SARS-CoV-2 neutralization.
    Rees-Spear C; Muir L; Griffith SA; Heaney J; Aldon Y; Snitselaar JL; Thomas P; Graham C; Seow J; Lee N; Rosa A; Roustan C; Houlihan CF; Sanders RW; Gupta RK; Cherepanov P; Stauss HJ; Nastouli E; ; Doores KJ; van Gils MJ; McCoy LE
    Cell Rep; 2021 Mar; 34(12):108890. PubMed ID: 33713594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 (beta) variant (20H/501Y.V2) in Brazil.
    Slavov SN; Patané JSL; Bezerra RDS; Giovanetti M; Fonseca V; Martins AJ; Viala VL; Rodrigues ES; Santos EV; Barros CRS; Marqueze EC; Santos B; Aburjaile F; Neto RM; Moretti DB; Haddad R; Calado RT; Kitajima JP; Freitas E; Schlesinger D; Junior de Alcantara LC; Elias MC; Sampaio SC; Kashima S; Covas DT
    J Med Virol; 2021 Dec; 93(12):6782-6787. PubMed ID: 34241897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody escape and global spread of SARS-CoV-2 lineage A.27.
    Kaleta T; Kern L; Hong SL; Hölzer M; Kochs G; Beer J; Schnepf D; Schwemmle M; Bollen N; Kolb P; Huber M; Ulferts S; Weigang S; Dudas G; Wittig A; Jaki L; Padane A; Lagare A; Salou M; Ozer EA; Nnaemeka N; Odoom JK; Rutayisire R; Benkahla A; Akoua-Koffi C; Ouedraogo AS; Simon-Lorière E; Enouf V; Kröger S; Calvignac-Spencer S; Baele G; Panning M; Fuchs J
    Nat Commun; 2022 Mar; 13(1):1152. PubMed ID: 35241661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2.
    Liu L; Iketani S; Guo Y; Chan JF; Wang M; Liu L; Luo Y; Chu H; Huang Y; Nair MS; Yu J; Chik KK; Yuen TT; Yoon C; To KK; Chen H; Yin MT; Sobieszczyk ME; Huang Y; Wang HH; Sheng Z; Yuen KY; Ho DD
    Nature; 2022 Feb; 602(7898):676-681. PubMed ID: 35016198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.
    Chen L; Zody MC; Di Germanio C; Martinelli R; Mediavilla JR; Cunningham MH; Composto K; Chow KF; Kordalewska M; Corvelo A; Oschwald DM; Fennessey S; Zetkulic M; Dar S; Kramer Y; Mathema B; Germer S; Stone M; Simmons G; Busch MP; Maniatis T; Perlin DS; Kreiswirth BN
    mSphere; 2021 Aug; 6(4):e0048021. PubMed ID: 34431691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion.
    Salleh MZ; Derrick JP; Deris ZZ
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.